Glycogen Synthase Kinase–3 and the Heart∗
Over the past decade, optimism has been high for the potential clinical significance of glycogen synthase kinase–3 (GSK-3) as a pharmacological target for ischemia and heart failure, as well as diabetes, Parkinson’s disease, and Alzheimer’s disease.
openaire +2 more sources
Defining the conformational landscape of glycogen synthase kinase 3 beta (GSK3β). [PDF]
Gurtu A, Laezza F.
europepmc +1 more source
Neuronal Overexpression of Glycogen Synthase Kinase-3β Accelerates Age-Related Glial, Vascular, and Inflammatory Remodeling of the Murine Dentate Gyrus. [PDF]
Prádanos-Senén AV +2 more
europepmc +1 more source
The inactivation of glycogen phosphorylase is not a prerequisite for the activation of liver glycogen synthase [PDF]
Ciudad, Carlos J. +2 more
openaire +2 more sources
Current Landscape of Glycogen Synthase Kinase-3β PET Tracers: Progress, Limitations, and Perspectives-A Narrative Review. [PDF]
Chen H +8 more
europepmc +1 more source
Inhibiting Glycogen Synthase Kinase 3 Suppresses TDP-43-Mediated Neurotoxicity in a Caspase-Dependent Manner. [PDF]
White MA +8 more
europepmc +2 more sources
Glycogen synthase AfGsy2 regulates mycelial growth, stress response, predatory activity, and chlamydospore development in the nematode-trapping fungus <i>Arthrobotrys flagrans</i>. [PDF]
Shi Q, Zhang Y, Mo M, Li G.
europepmc +1 more source
Retraction: In silico investigation of novel Plasmodium Falciparum glycogen synthase kinase (pfGSk3β) inhibitors for the treatment of malaria infection. [PDF]
PLOS One Editors.
europepmc +1 more source
Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in <i>Leishmania infantum</i>. [PDF]
Cruz MGFdML +8 more
europepmc +1 more source
Regulation of Glycogen Synthase
Bartholomew A. Pederson +3 more
openaire +1 more source

